Skip to main content

Table 2 Classification of funding source and competing interests in the included systematic reviews

From: Identifying competing interest disclosures in systematic reviews of surgical interventions and devices: a cross-sectional survey

  Overall
(n = 155)
CSR
(n = 25)
Non-CSR
(n = 130)
Source of funding
 Industry funding 3 (1.9) 0 (0) 3 (2.3)
 Non-industry funding 42 (27.1) 20 (80.0) 22 (16.9)
 Industry + non-industry funding 1 (0.6) 0 (0) 1 (0.8)
 Reported as not funded 45 (29.0) 1 (4.0) 44 (33.8)
 Not reported 64 (41.3) 4 (16.0) 60 (46.2)
Types of competing interests
 No competing interest to disclose 111 (71.6) 12 (48.0) 99 (76.2)
At least one type
 Grant/fellowship 17 (11.0) 6 (24.0) 11 (8.5)
 Honoraria 15 (9.7) 2 (8.0) 13 (1.0)
 Consulting 14 (9.0) 4 (16.0) 10 (7.7)
 Non-monetary support 8 (5.2) 5 (20.0) 3 (2.3)
 Service in other affiliations 8 (5.2) 2 (8.0) 6 (4.6)
 Equity/stocks/bonds 3 (1.9) 1 (4.0) 2 (1.5)
 Patent 2 (1.3) 0 (0) 2 (1.5)
 Employment/salary 1 (0.6) 1 (4.0) 0 (0)
 Leadership in company 1 (0.6) 0 (0) 1 (0.8)
  Intellectual beliefs 6 (3.8) 4 (16.0) 2 (1.5)
 Experience 3 (1.9) 2 (8.0) 1 (0.8)
 Personal relationship 2 (1.3) 2 (8.0) 0 (0)
  1. Values in parentheses are percentages
  2. CSR Cochrane systematic review